ArticleAnnals of surgical oncology2026

Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma.

Bin Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.